Topical sirolimus for the treatment of verrucous epidermal nevus associated with an HRAS mosaic mutation: a case report
Authors:
Open Access
- 24 August 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1932228
Abstract
Introduction: Verrucous epidermal nevus is a benign epidermal hamartoma associated with somatic mosaic mutations, which shows poor response to conventional therapies and has a high risk of recurrence. To date, there are no standardized treatment guidelines for this condition. In recent years, targeted treatments for specific gene mutations have provided new directions for the clinical management of this disease. Case report: We report a case of a 13-year-old child with verrucous epidermal nevus in whom genetic testing revealed an HRAS mosaic mutation. The child showed poor response to conventional treatments, including surgical excision, topical retinoic acid cream, and oral acitretin. However, after treatment with topical 0.5% (w/w) sirolimus ointment, the child’s skin lesions showed reduced area, thinning, improved pigmentation, and decreased roughness, and no local or systemic adverse reactions were observed during the 6-month treatment period. Conclusion: This case suggests that topical sirolimus may represent a potentially effective therapeutic option for patients with verrucous epidermal nevus who are refractory to conventional therapy.Keywords
This publication has 21 references indexed in Scilit:
- De Novo Germline L858R EGFR Variants and Generalized Acanthosis NigricansJAMA Dermatology, 2026
- Postzygotic Gain-of-Function Variant in TRPM4 and Inflammatory Linear Verrucous Epidermal NevusJAMA Dermatology, 2025
- Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case seriesJournal of the American Academy of Dermatology, 2022
- Molecular Genetic Dissection of Inflammatory Linear Verrucous Epidermal Naevus Leads to Successful Targeted TherapyJournal of Investigative Dermatology, 2021
- Topical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysisJournal of the American Academy of Dermatology, 2019
- Inflammatory Linear Verrucous Epidermal Nevus with a Postzygotic GJA1 Mutation Is a Mosaic Erythrokeratodermia Variabilis et ProgressivaJournal of Investigative Dermatology, 2017
- Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis ComplexJAMA Dermatology, 2017
- Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosisInternational Journal of Dermatology, 2015
- Hyperactive Ras in developmental disorders and cancerNature Reviews Cancer, 2007
- Mosaicism for ATP2A2 Mutations Causes Segmental Darier's DiseaseJournal of Investigative Dermatology, 2000